Begin with the reason for treatment
Pregnancy planning is not just a question of which date to stop a medicine. The prescriber also needs to know why it was started, what other conditions require care and who will manage them during the transition. FDA recommends discussing medicines before pregnancy. Bring prescription and nonprescription products to that conversation, including supplements. A plan made with only the weight-management clinic may leave questions for the clinician who manages diabetes or another condition.[2]
A product label is more precise than a class slogan
Wegovy’s current labeling includes a two-month interval before planned pregnancy and indication-specific pregnancy wording, including separate consideration for MASH. The practical point is to have the prescriber interpret the current label for the reason you receive treatment. Do not copy an internet stopping interval onto another medication or decide that a specialist indication has the same risk-benefit discussion as weight reduction. Exact product, indication and reproductive plan all belong in the same decision.[1] For a related question, see tirzepatide and oral contraception.
Distinguish absence of evidence from reassurance
Limited pregnancy information does not establish that exposure is harmless. Equally, a warning does not determine the outcome of an individual pregnancy. For someone who discovers an exposure after conception, the next useful step is prompt communication with the prescribing and pregnancy-care teams. Record the product and relevant dates accurately. Avoid trying to estimate fetal risk from a weight-loss trial, since such a study was designed to answer a different question in a different population.
Ask about the transition, not only the last prescription
A written plan should identify the clinician responsible for ongoing care, the conditions to monitor, and the point at which the plan will be reviewed. Ask whether other medicines also need reassessment and how to contact the team between visits. This is especially useful when prescriptions come from multiple services. Do not independently replace a prescribed medicine with a supplement advertised as a pregnancy-safe alternative; a marketing description cannot establish that an alternative meets the same medical need.[2] Read more: how to assess a care provider.
Know what an exposure registry does
FDA explains that pregnancy exposure registries collect information about people who used medicines during pregnancy. Participation can contribute evidence, but a registry is not a substitute for medical care and does not itself determine whether a drug caused an outcome. If exposure has occurred, ask the clinician whether an appropriate registry exists and what participation involves. Keep the clinical discussion and the research contribution separate so neither is mistaken for an individualized safety guarantee.[2]
Carry the plan across appointments
Keep a concise record of the medicine, indication, pregnancy intentions, clinicians involved and agreed follow-up. If care moves to another practice, provide that record rather than starting from a general statement that you previously used a GLP-1. When reading future studies, look for the actual exposure window, comparison group and outcome measured. Pregnancy planning requires patient-specific care; a reassuring headline or an alarming anecdote cannot replace those details. Read more: how to read GLP-1 research.
Keep indication and product visible in records
A chart entry that says only “weight-loss medication” can omit information another clinician needs. Ask for the actual medicine name and the condition being treated to appear in the handoff. If the reason for treatment has changed, update the record. Clear documentation makes it easier for the pregnancy-care team to interpret the relevant label and arrange the appropriate specialist conversation.
Continue your research
Sources & scope
Sources checked October 13, 2026. This guide explains published information and consumer research questions; it is not a clinical evaluation.
Prices and terms can change. Confirm your specific offer directly with the provider.